RESUMO
Bladder inguinal hernias are infrequently encountered in clinical practice. When present, the patient's main concern may be urinary difficulties such as retention. Careful history and physical examination will reveal the diagnosis in most cases, however, advanced imaging may be required. Emergent surgical consultation is required and urological consultation may be needed for preoperative planning and assistance. We present a case of a patient with almost complete herniation of bladder into left inguinal canal into the left hemiscrotum.
Assuntos
Hérnia Inguinal/diagnóstico , Doenças da Bexiga Urinária/diagnóstico , Retenção Urinária/etiologia , Idoso , Hérnia Inguinal/complicações , Humanos , Masculino , Doenças da Bexiga Urinária/complicaçõesRESUMO
AIM: To determine patient/carer expectations of continuous glucose monitoring (CGM) and short-term satisfaction, to assess the efficacy of CGM in improving: fear of hypoglycaemia and glycaemic control (HbA1c , ketosis, hypoglycaemia) and to determine time requirements of diabetes clinic staff in commencing and administering CGM. METHODS: We assessed CGM-naïve patients starting on CGM at a Sydney Diabetes Centre following the introduction of a nationwide government subsidy for CGM. A standardised questionnaire was administered collecting demographic and glycaemic information in addition to Likert scale assessment of expectations and satisfaction. Clinic staff reported time dedicated to CGM education, commencement and follow-up. RESULTS: A total of 55 patients or parents/carers completed baseline questionnaires, with 37 completing a 3-month follow-up questionnaire. There were high expectations of CGM prior to commencement and high satisfaction ratings on follow-up. CGM improved fear of hypoglycaemia, and total daily insulin dose increased after commencement of CGM. There was a trend towards lower HbA1c that was not statistically significant and no statistically significant reduction in ketosis or hypoglycaemia. Comments were mostly positive, with some concern raised regarding technical issues and a lack of subsidy after 21 years of age. Staff time requirements were substantial, with an estimated average of 7.7 h per patient per year. CONCLUSIONS: Patients and families have high expectations of CGM, and satisfaction levels are high in the short term. Total insulin delivery increased after CGM commencement. Time requirements by staff are substantial but are worthwhile if families' overall satisfaction levels are high.
Assuntos
Automonitorização da Glicemia , Diabetes Mellitus Tipo 1 , Programas Governamentais , Adolescente , Assistência Ambulatorial , Criança , Medo , Feminino , Humanos , Hipoglicemia/psicologia , Sistemas de Infusão de Insulina , Masculino , New South Wales , Satisfação do Paciente , Inquéritos e Questionários , Adulto JovemRESUMO
OBJECTIVES: To evaluate the effects of a collaborative pharmacy benefits manager (PBM)/ health plan-administered drug therapy management (DTM) program on healthcare utilization and costs in patients with diabetes treated with polypharmacy. STUDY DESIGN: Retrospective quasi-experimental design with comparison group. METHODS: This DTM program was a collaborative effort between the PBM, PerformRx, and the care management departments of Keystone First (KF) and AmeriHealth Caritas Pennsylvania (ACP) care management departments, targeting patients with diabetes using >15 medications. Pharmacists reviewed member profiles and made evidencebased prescriber and patient interventions, working directly with prescribers and indirectly with members, via care managers. Care managers provided additional services not otherwise within the scope of DTM. The study group consisted of 954 DTM participants reviewed by a pharmacist between November 1, 2010, and July 31, 2011. The control group consisted of 810 matched DTM participants not reviewed by a pharmacist. RESULTS: Intervention acceptance rates for KF and ACP were 33% and 26%, respectively. The study group demonstrated lower inpatient admissions and emergency department utilization rates, although only the KF study group inpatient admission rate achieved statistical significance (76.4%; P = .0002). The study groups realized statistically significant total cost savings (pharmacy + medical) compared with their corresponding control groups (47.8% KF, P = .0039; 50.7% ACP, P = .0497) despite non-statistically significant increases in pharmacy costs. CONCLUSIONS: A collaborative pharmacist-driven DTM program with a care manager-executed patient outreach component results in reduced hospital utilization and significant healthcare cost savings.